June 15, 2021
1 min read

‘AstraZeneca jab authorised for all age-groups’

The EU has also authorised Pfizer-BioNTech and Moderna’s mRNA based Covid-19 vaccines…reports Asian Lite News.

AstraZeneca’s Covid-19 vaccine remains authorised for all populations, European Medicines Agency (EMA) has said.

The clarification camme after Italian newspaper La Stampa earlier quoted Marco Cavaleri, head of the EMA’s vaccine strategy, recommending a stop to administration of AstraZeneca’s Covid shots in Europe to people aged over 60 and younger age groups, amid fears over very rare blood clotting.

“Misinformation is making the rounds today. This is the situation: Benefit/risk balance of AstraZeneca #Covid19 vaccine is positive and it remains authorised for all populations,” the EMA said in a tweet on Sunday.

Cavaleri was also quoted by the newspaper advising the use of the Johnson & Johnson vaccine preferentially for the over-60s.

The European Union has approved AstraZeneca and Johnson & Johnson vaccines for all populations aged 18 and above. However, both viral vector-based jabs have been marred by various reports of rare blood clots.

The EU has also authorised Pfizer-BioNTech and Moderna’s RNA based Covid-19 vaccines.
Asked by the newspaper whether it would be better to stop using AstraZeneca for all age groups, Cavaleri had said: “Yes, and it is an option that many countries, such as France and Germany, are considering in the light of the increased availability of mRNA vaccines.”

“However, incidents were very rare after the first dose. It is true that there is less data on the second dose, but in the United Kingdom it (the vaccination programme) is going well,” he added.

On June 11, Italy restricted the use of AstraZeneca doses to those aged 60 years and above, after a teenager who had received the shot died from a rare form of blood clotting.

In March, the two-dose vaccine was briefly halted by many European countries, including Italy, over concerns about the rare blood clotting problems.

But, its usage was resumed in April, after the EMA said its benefits outweighed any risks.

ALSO READ-Japan approves Moderna, AstraZeneca jabs

READ MORE-EU sues AstraZeneca for contract breach

Previous Story

Afghan forces capture key Taliban commander

Next Story

‘China’s three-child policy won’t prevent lower annual births’

Latest from -Top News

US Urges India to Rethink Russian Oil Imports

Wright emphasised the priority of ending the conflict while strengthening US-India ties…reports Asian Lite News United States Energy Secretary Chris Wright urged India to reassess its oil imports from Russia, stressing that

Trump, Shehbaz Set for Oval Office Talks

Sharif will arrive in Washington after attending the 80th United Nations General Assembly in New York….reports Asian Lite News US President Donald Trump will hold high-stakes bilateral meetings on Thursday, including a

Farooq Abdullah Urges Dialogue After Ladakh Unrest

Dr Farooq Abdullah warned the Central government that neglecting their long-standing demands could deepen unrest in the sensitive Himalayan region….reports Asian Lite News Former Jammu and Kashmir Chief Minister and National Conference

Nepal lets Gen-Z in on the vote

Nepal clears way for Gen-Z voters with urgent ordinance, as interim PM Sushila Karki expands cabinet, prepares for March 2026 polls, and secures strong support from India….reports Asian Lite News Nepal has

Jaishankar pushes for UNSC reforms 

India hosts joint ministerial with L69 and C10 blocs as External Affairs Minister deepens diplomatic outreach on UNGA sidelines…reports Asian Lite News External Affairs Minister, S Jaishankar, on Wednesday placed the spotlight
Go toTop

Don't Miss

AstraZeneca admits to side effects of Covid vaccine

AstraZeneca has made the admission in court documents in connection

Mamata meets Modi, demands more vaccines, medicines

Banerjee also discussed several different projects of the state and